Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Other financing activities: 2023-2025

Historic Other financing activities for Mereo BioPharma Group (MREO) over the last 1 years, with Jun 2025 value amounting to $134,000.

  • Mereo BioPharma Group's Other financing activities fell 38.81% to $134,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $833,000, marking a year-over-year change of. This contributed to the annual value of $853,000 for FY2024, which is 66.93% up from last year.
  • Mereo BioPharma Group's Other financing activities amounted to $134,000 in Q2 2025, which was up 106.15% from $65,000 recorded in Q1 2025.
  • Over the past 5 years, Mereo BioPharma Group's Other financing activities peaked at $594,000 during Q3 2024, and registered a low of $40,000 during Q4 2024.
  • Moreover, its 3-year median value for Other financing activities was $176,500 (2024), whereas its average is $255,000.
  • Data for Mereo BioPharma Group's Other financing activities shows a maximum YoY crashed of 91.63% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Mereo BioPharma Group's Other financing activities stood at $478,000 in 2023, then crashed by 91.63% to $40,000 in 2024, then crashed by 38.81% to $134,000 in 2025.
  • Its Other financing activities was $134,000 in Q2 2025, compared to $65,000 in Q1 2025 and $40,000 in Q4 2024.